National Institute of Allergy and Infectious Diseases (NIAID)
This Notice of Special Interest (NOSI) is specifically designed to promote partnerships between eligible NIAID-funded extramural research investigators and NIAID intramural research investigators (i.e., those conducting research within the laboratories and clinics of NIAID). The intent is to foster and stimulate basic, translational, and applied research that will advance scientific discovery and engage extramural researchers working collaboratively in the areas of immunology, infectious diseases, and allergy. This NOSI will provide funding to NIAID-supported extramural research investigator to travel to NIAID laboratories for a short duration to perform research in partnership with a host intramural research investigator.
Section 301(a)(2) of the Public Health Service (PHS) Act authorizes the Secretary to ...make available research facilities of the Service to appropriate public authorities, and to health officials and scientists engaged in special study. Collaborative research is essential for scientists in different laboratories to move their research forward by sharing common questions, resources, and information.
The NIAID Division of Intramural Research (DIR) is a research community of about 130 principal investigators who lead about 1,200 colleagues composed of scientists, physicians, trainee fellows, technical personnel, and students. The NIAID DIR has laboratories in multiple locations in the Bethesda, Maryland area and a location in Hamilton, Montana. Both the Maryland and Rocky Mountain Laboratories (RML) locations have world-class programs in allergy, immunology, and infectious diseases, biosafety level (BSL)-2, BSL-3, and/or BSL-4 laboratory spaces.
Please consult the FAQ for additional information on this opportunity and about DIR Investigators with an interest in participating in this program.
Every facet of the United States scientific research enterprise—from basic laboratory research to clinical and translational research to policy formation–requires superior intellect, creativity and a wide range of skill sets and viewpoints. NIHs ability to help ensure that the nation remains a global leader in scientific discovery and innovation is dependent upon a pool of highly talented scientists from diverse backgrounds who will help to further NIHs mission. Research shows that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogenous teams. Scientists and trainees from diverse backgrounds and life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems. There are many benefits that flow from a diverse NIH-supported scientific workforce, including: fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of the research, advancing the likelihood that underserved or health disparity populations participate in, and benefit from health research, and enhancing public trust. NIH encourages applicants to include a diverse group of scientists in their research programs, including individuals from underrepresented backgrounds (see NOT-OD-20-031, Notice of NIHs Interest in Diversity and NOT-OD-22-019, Reminder: Notice of NIHs Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities).
This NOSI will support research on all aspects of immunological and infectious diseases, including causative agents, vectors, and pathogenesis. Some areas of scientific interest include, but are not limited to:
In addition, applicants are encouraged to engage in collaborations that support the following outcomes:
Applicants must include a statement describing how they incorporate diverse perspectives into NIAID-supported biomedical research. Examples may include for example:
Applicants must include a letter of support from the PD/PI of the NIAID intramural research laboratory where the extramural investigator will be conducting research.
Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.